THE IMPACT OF AMINO ACIDS ON CHANGES IN FLUID AND FAT TISSUE CONTENT IN RATS WITH TYPE 2 DIABETES MELLITUS

Authors

DOI:

https://doi.org/10.32782/2226-2008-2026-1-1

Keywords:

bioimpedance analysis of body composition, type 2 diabetes mellitus, L-arginine, N-acetyl-L-cysteine, rats

Abstract

The aim of the study was to determine the body composition of rats with experimental type 2 diabetes mellitus, and to assess the impact of amino acid correction on these parameters using bioelectrical impedance analysis. Materials and methods. Type 2 diabetes mellitus was induced with streptozotocin (30 mg/kg) in rats with insulin resistance. Two experimental subgroups received L-arginine or N-acetyl-L-cysteine, while the diabetic control group received drinking water. Glucose levels, body weight, and body composition were measured. Results. Streptozotocin administration caused persistent hyperglycemia and body mass reduction, primarily due to fat loss, despite a slight increase in lean body mass. However, the lean body mass remained lower than in the control group. These changes led to overall dehydration caused by reduced extracellular and intracellular fluid volumes, while their ratio was preserved. L-arginine and N-acetyl-L-cysteine reduced glucose levels by 14 % and 13 %, respectively, compared to the untreated diabetic group. Despite the reduction in glucose levels, all diabetic subgroups experienced progressive dehydration, without significant differences in total body weight, fat, or lean body mass mass. The fat-tolean mass ratio in amino acid-treated groups was 1:5, significantly different from the 1:6 ratio observed in untreated diabetic rats. Conclusion. Modeling type 2 diabetes mellitus in rats with insulin resistance leads to changes in body composition in rats, including fat mass loss and general dehydration. Amino acid correction reduces glucose levels but does not prevent alterations in water and fat metabolism.

References

Ruze R, Liu T, Zou X, et al. Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments. Front Endocrinol (Lausanne). 2023 Apr 21;14:1161521. https://doi.org/10.3389/fendo.2023.1161521. PMID: 37152942; PMCID: PMC10161731.

World Health Organization. Diabetes. [Internet]. 2023 Apr 5. Available from: https://www.who.int/news-room/fact-sheets/detail/diabetes.

Srinivasan V, Radhakrishnan S, Angayarkanni N, Sulochana KN. Antidiabetic effect of free amino acids supplementation in human visceral adipocytes through adiponectin-dependent mechanism. Indian J Med Res. 2019 Jan;149(1):41–46. https://doi.org/10.4103/ijmr.ijmr_1782_16. PMID: 31115373; PMCID: PMC6507535.

Forzano I, Avvisato R, Varzideh F, et al. Correction: L-Arginine in diabetes: clinical and preclinical evidence. Cardiovasc Diabetol. 2023 May 18;22(1):117. DOI: 10.1186/s12933-023-01852-1. Erratum for: Cardiovasc Diabetol. 2023 Apr 18;22(1):89. https://doi.org/10.1186/s12933-023-01852-1. PMID: 37208744; PMCID: PMC10197449.

Wang P, Ma H, Hou X, Song L, Feng M. N-acetyl-L-cysteine ameliorates gestational diabetes mellitus by inhibiting oxidative stress. Biotechnol Appl Biochem. 2023 Jun;70(3):1128–1136. https://doi.org/10.1002/bab.2426. Epub 2022 Dec 27. PMID: 36517965.

Bajwa NS, Aslam MW, ul Amin MR, et al. Comparative study of metformin, N-acetylcysteine and L-arginine on hyperglycemia in streptozotocin-induced diabetic rats. Pak J Med Health Sci. 2022;16(02):508–508. https://doi.org/10.53350/pjmhs22162508.

Pouragha H, Amiri M, Saraei M, Pouryaghoub G, Mehrdad R. Body impedance analyzer and anthropometric indicators; predictors of metabolic syndrome. J Diabetes Metab Disord. 2021 Jul 13;20(2):1169–1178. https://doi.org/10.1007/s40200-021-00836-w. PMID: 34277496; PMCID: PMC8275900.

Catapano A, Trinchese G, Cimmino F, et al. Impedance Analysis to Evaluate Nutritional Status in Physiological and Pathological Conditions. Nutrients. 2023 May 10;15(10):2264. https://doi.org/10.3390/nu15102264. PMID: 37242147; PMCID: PMC10224243.

Sun Z, Liu Y, Zhao Y, Xu Y. Animal Models of Type 2 Diabetes Complications: A Review. Endocr Res. 2024 Jan 2;49(1):46–58. https://doi.org/10.1080/07435800.2023.2278049. Epub 2024 Jan 4. PMID: 37950485.

Cortés-Álvarez NY, Vuelvas-Olmos CR, Pinto-González MF, Guzmán-Muñiz J, Gonzalez-Perez O, Moy-López NA. A high-fat diet during pregnancy impairs memory acquisition and increases leptin receptor expression in the hippocampus of rat offspring. Nutr Neurosci. 2022 Jan;25(1):146–158. https://doi.org/10.1080/1028415x.2020.1728473. Epub 2020 Feb 19. PMID: 32075550.

Kolesnyk YM, Isachenko MI. Modeling insulin resistance in Wistar rats induced by a combined high-fat diet as a predictor of type 2 diabetes (experimental phase 1 study). Pathologia. 2025;22(1):5–11. https://doi.org/10.14739/2310-1237.2025.1.314277.

ImpediMed Limited. Vet BIS1 instructions for use. [n.d.]. Available from: https://support.brck.co.jp/download_file/force/280/511.

Kolesnyk YM, Isachenko MI. Analysis of the body composition of rats with experimental diabetes mellitus type 1 and its correction. Modern Medical Technology. 2024;16(4):247–254. https://doi.org/10.14739/mmt.2024.4.311425.

Costa G, Shushanof M, Bouskela E, Bottino D. Oral L-Arginine (5 g/day) for 14 Days Improves Microcirculatory Function in Healthy Young Women and Healthy and Type 2 Diabetes Mellitus Elderly Women. J Vasc Res. 2022;59(1):24–33. https://doi.org/10.1159/000519428. Epub 2021 Nov 16. PMID: 34784595.

Schuurman M, Wallace M, Sahi G. N-acetyl-L-cysteine treatment reduces beta-cell oxidative stress and pancreatic stellate cell activity in a high fat diet-induced diabetic mouse model. Front Endocrinol (Lausanne). 2022 Aug 25;13:938680. https://doi.org/10.3389/fendo.2022.938680. PMID: 36093092; PMCID: PMC9452715.

Magalhães DA, Kume WT, Correia FS. High-fat diet and streptozotocin in the induction of type 2 diabetes mellitus: a new proposal. An Acad Bras Cienc. 2019 Mar 21;91(1):e20180314. https://doi.org/10.1590/0001-3765201920180314. PMID: 30916157.

Bays HE. Why does type 2 diabetes mellitus impair weight reduction in patients with obesity? A review. Obes Pillars. 2023 Jun 13;7:100076. https://doi.org/10.1016/j.obpill.2023.100076. PMID: 37990681; PMCID: PMC10661899.

Downloads

Published

2026-03-30

Issue

Section

THEORY AND EXPERIMENT